﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Nickan Research Institute</PublisherName>
      <JournalTitle>Immunopathologia Persa</JournalTitle>
      <Issn>2423-8015</Issn>
      <Volume>4</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2018</Year>
        <Month>07</Month>
        <DAY>01</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Fungal peritonitis in continuous ambulatory peritoneal dialysis patients; a study from South of India</ArticleTitle>
    <FirstPage>e15</FirstPage>
    <LastPage>e15</LastPage>
    <ELocationID EIdType="doi">10.15171/ipp.2018.15</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Renukaprasad Yelahanka</FirstName>
        <LastName>Suryanarayana</LastName>
      </Author>
      <Author>
        <FirstName>Indhumathi</FirstName>
        <LastName>Elumalai</LastName>
      </Author>
      <Author>
        <FirstName>Gnanasambandan</FirstName>
        <LastName>Ramanathan</LastName>
      </Author>
      <Author>
        <FirstName>Ramprasad</FirstName>
        <LastName>Elumalai</LastName>
      </Author>
      <Author>
        <FirstName>Jayakumar</FirstName>
        <LastName>Matcha</LastName>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.15171/ipp.2018.15</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2017</Year>
        <Month>12</Month>
        <Day>03</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2018</Year>
        <Month>01</Month>
        <Day>19</Day>
      </PubDate>
    </History>
    <Abstract>Introduction: Fungal peritonitis is a potential life-threatening complication for patients undergoing continuous ambulatory peritoneal dialysis (CAPD). Objectives: To assess the incidence and outcome of fungal peritonitis in CAPD patients. Patients and Methods: Dialysis records of all end-stage renal disease patients initiated on CAPD treatment were reviewed retrospectively. The study was conducted during January 2010 to December 2016. Mann–Whitney U test was applied for data analysis. Results: Out of 265 dialysis patients, a total of 36 fungal peritonitis were recorded. The incidence rate of fungal peritonitis was 13.6%. The majority of cases was affected by Candida albicans was 41.6%. Moreover, the major cause of end-stage renal disease (ESRD) in our study was diabetic nephropathy in 38.8% of cases. Conclusion: In this study, we found initiation of antifungal therapy and early removal of catheter reduced the mortality rate of fungal peritonitis in CAPD patients.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Fungal peritonitis</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Continuous ambulatory peritoneal dialysis</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">End-stage renal disease</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>